January 07, 2021
Sage Therapeutics
Sage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conference
January 07, 2021
Constellation Pharmaceuticals
Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer
January 07, 2021
Kala Pharmaceuticals
Kala Pharmaceuticals Announces Availability of EYSUVIS™ for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline
January 07, 2021
Nurix
Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies
January 05, 2021
Bristol Myers Squibb and bluebird bio Present Data Highlighting Anti-BCMA CAR T Cell Therapy, Ide-cel, in Relapsed and Refractory Multiple Myeloma at ASH 2020